Table 1.
Demographic, Clinical, and Medication-Related Characteristics of Children With Medical Complexity and Complex Medication Regimens (N = 156)
| Characteristic | Result |
|---|---|
| Age, n (%), yr | |
| <1 | 7 (4.5) |
| 1–4 | 39 (25) |
| 5–9 | 53 (34) |
| 10–12 | 23 (14.5) |
| 13–18 | 34 (22) |
| Sex, n (%) | |
| Male | 78 (50) |
| Female | 78 (50) |
| Race, n (%) | |
| Caucasian | 117 (75) |
| African American | 9 (5.8) |
| Hispanic/Latino | 2 (1.3) |
| Asian | 2 (1.3) |
| Hawaiian/Pacific Islander | 1 (0.6) |
| American Indian/Alaska Native | 3 (1.9) |
| Other/unknown | 22 (14.1) |
| Complex chronic condition, n (%) | 156 (100) |
| Neurological impairment, n (%) | 120 (77) |
| Number of medications in all patients, median (IQR) | 8 (5–10) |
| ≥10 Medications | |
| Patients receiving, % | 23.1 |
| Number of medications, median (IQR) | 11 (10–13) |
| ≥1 High-risk medication | |
| Patients receiving, % | 95.5 |
| Number of high risk medications, median (IQR) | 3 (2–4) |
| ≥1 Compounded medication | |
| Patients receiving, % | 35.9 |
| Number of compounded medications, median (IQR) | 1 (1–2) |
| Receipt of Home Nursing, n (%) | 79 (50.6) |
| Medications Administered by Family at Home, % | |
| 0–24 | 9.0 |
| 25–49 | 4.5 |
| 50–74 | 13.5 |
| 75–100 | 70.5 |
| Unknown | 2.5 |